Letters to the Editor

Prior anti-BCMA antibody-drug conjugate exposure does not impact long-term outcomes with subsequent anti-BCMA T-cell-engaging bispecific antibodies: a single-center real-world data analysis

The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital Foundation NHS Trust, London, United Kingdom; University Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino
The Royal Marsden Hospital Foundation NHS Trust, London
The Royal Marsden Hospital Foundation NHS Trust, London
The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital Foundation NHS Trust, London
Epsom and St Helier University Hospitals, Carshalton
The Royal Marsden Hospital Foundation NHS Trust, London
The Royal Marsden Hospital Foundation NHS Trust, London
The Royal Marsden Hospital Foundation NHS Trust, London
The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital Foundation NHS Trust, London
Haematologic Malignancies Diagnostic Service and Genomics Laboratory Hub, The Royal Marsden Hospital, London
The Royal Marsden Hospital Foundation NHS Trust, London
University Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino
The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital Foundation NHS Trust, London
The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital Foundation NHS Trust, London
The Institute of Cancer Research, London, United Kingdom; The Royal Marsden Hospital Foundation NHS Trust, London
Haematologica Early view Aug 27, 2026 https://doi.org/10.3324/haematol.2026.301383